Higher frequencies for KIR2DS4 in severe COVID-19 patients and KIR3DS1+HLA-B*15:01+ in mild/moderate cases of COVID-19 than in control in Spanish indicate a potentially detrimental effect of activating KIR in COVID-19 (Bernal et al., 2021). The gene discussed is HLA-B; the disease is COVID-19.